-
Abedon S, 2011: Phage therapy pharmacology: calculating phage dosing[J]. Adv Appl Microbiol, 77, 10-40.
-
Abedon ST, 1990: Selection for lysis inhibition in bacteriophage[J]. J Theor Biol, 146, 501-511. doi: 10.1016/S0022-5193(05)80375-3
-
Abedon ST, 1992: Lysis of lysis inhibited bacteriophage T4-infected cells[J]. J Bacteriol, 174, 8073-8080. doi: 10.1128/jb.174.24.8073-8080.1992
-
Abedon ST. 1994. Lysis and the interaction between free phages and infected cells. In: The Molecular Biology of Bacteriophage T4. Karam JD, Kutter E, Carlson K, and Guttman B (eds). Washington DC: ASM Press, pp397-405.
-
Abedon ST, 1999: Bacteriophage T4 resistance to lysis-inhibition collapse[J]. Genet Res, 74, 1-11. doi: 10.1017/S0016672399003833
-
Abedon ST. 2008. Phage population growth: constraints, games, adaptation. In: Bacteriophage Ecology. Abedon ST (ed). Cambridge: Cambridge University Press, pp64-93.
-
Abedon ST. 2009a. Bacteriophage intraspecific cooperation and defection. In: Contemporary Trends in Bacteriophage Research.
-
Adams HT (ed). Hauppauge: Nova Science Publishers, pp191-215.
-
Abedon ST. 2009b. Disambiguating bacteriophage pseudolysogeny: an historical analysis of lysogeny, pseudolysogeny, and the phage carrier state. In: Contemporary Trends in Bacteriophage Research. Adams HT (ed). Hauppauge: Nova Science Publishers, pp285-307.
-
Abedon ST, 2009c: Kinetics of phage-mediated biocontrol of bacteria[J]. Foodborne Pathog Dis, 6, 807-815. doi: 10.1089/fpd.2008.0242
-
Abedon ST. 2011a. Bacteriophages and Biofilms: Ecology, Phage Therapy, Plaques. Hauppauge: Nova Science Publishers.
-
Abedon ST. 2011b. Lysis from without. Bacteriophage. 1: 46-49.
-
Abedon ST. 2012a. Phage therapy best practices. In: Bacteriophages in Health and Disease. Hyman P, Abedon ST (eds). Wallingford: CABI Press, pp256-272.
-
Abedon ST, 2012b: Spatial vulnerability: bacterial arrangements, microcolonies, and biofilms as responses to low rather than high phage densities[J]. Viruses, 4, 663-687. doi: 10.3390/v4050663
-
Abedon ST, 2012c: Thinking about microcolonies as phage targets[J]. Bacteriophage, 2, 200-204. doi: 10.4161/bact.22444
-
Abedon ST. 2014. Bacteriophages as drugs: the pharmacology of phage therapy. In: Phage Therapy: Current Research and Applications. Borysowski J, Miedzybrodzki R, and Górski A (eds). Norfolk: Caister Academic Press, pp69-100.
-
Abedon ST, Kuhl SJ, Blasdel BG, Kutter EM, 2011: Phage treatment of human infections[J]. Bacteriophage, 1, 66-85. doi: 10.4161/bact.1.2.15845
-
Abedon ST, Thomas-Abedon C, 2010: Phage therapy pharmacology[J]. Curr Pharm Biotechnol, 11, 28-47. doi: 10.2174/138920110790725410
-
Adams MH. 1959. Bacteriophages. New York: InterScience.
-
Barron BA, Fischetti VA, Zabriskie JB, 1970: Studies of the bacteriophage kinetics of multicellular systems: a statistical model for the estimation of burst size per cell in streptococci[J]. J Appl Bacteriol, 33, 436-442. doi: 10.1111/jam.1970.33.issue-2
-
Benzer S, Hudson W, Weidel W, Delbruck M, Stent GS, Weigle J J, Dulbecco R, Watson JD, Wollman EL. 1950. A syllabus on procedures, facts, and interpretations in phage. Viruses 1950. Delbruck M (ed). Pasadena: California Institute of Technology, pp100-147.
-
Berngruber TW, Weissing FJ, Gandon S, 2010: Superinfection inhibition and the evolution of viral latency[J]. J Virol, 84, 10200-10208. doi: 10.1128/JVI.00865-10
-
Bigwood T, Hudson JA, Billington C, 2009: Influence of host and bacteriophage concentrations on the inactivation of foodborne pathogenic bacteria by two phages[J]. FEMS Microbiol Lett, 291, 59-64. doi: 10.1111/fml.2009.291.issue-1
-
Bull JJ, Regoes RR, 2006: Pharmacodynamics of non-replicating viruses, bacteriocins and lysins[J]. Proc R Soc Lond B Biol Sci, 273, 2703-2712. doi: 10.1098/rspb.2006.3640
-
Chan BK, Abedon ST, 2012: Phage therapy pharmacology: phage cocktails[J]. Adv Appl Microbiol, 78, 1-23. doi: 10.1016/B978-0-12-394805-2.00001-4
-
Chan BK, Abedon ST, Loc-Carrillo C, 2013: Phage cocktails and the future of phage therapy[J]. Future Microbiol, 8, 769-783. doi: 10.2217/fmb.13.47
-
Davis BM, Kimsey HH, Chang W, Waldor MK, 1999: The Vibrio cholerae O139 Calcutta bacteriophage CTXφ is infectious and encodes a novel repressor[J]. J Bacteriol, 181, 6779-6787.
-
Doermann AH, 1948: Lysis and lysis inhibition with Escherichia coli bacteriophage[J]. J Bacteriol, 55, 257-275.
-
Espeland EM, Lipp EK, Huq A, Colwell RR, 2004: Polylysogeny and prophage induction by secondary infection in Vibrio cholerae[J]. Environ Microbiol, 6, 760-763. doi: 10.1111/emi.2004.6.issue-7
-
Fogg PC, Allison HE, Saunders JR, McCarthy AJ, 2010: Bacteriophage lambda: a paradigm revisited[J]. J Virol, 84, 6876-6879. doi: 10.1128/JVI.02177-09
-
Fogg PCM, Gossage SM, Smith DL, Saunders JR, McCarthy AJ, Allison HE, 2007: Identification of multiple integration sites for Stx-phage φ24B in the Escherichia coli genome, description of a novel integrase and evidence for a functional anti-repressor[J]. Microbiology, 153, 4098-4110. doi: 10.1099/mic.0.2007/011205-0
-
French RC, Graham AF, Lesley SM, van Rooyen CE, 1952: The contribution of phosphorus from T2r+ bacteriophage to progeny[J]. J Bacteriol, 64, 597-607.
-
Fukuda E, Kaminska KH, Bujnicki JM, Kobayashi I, 2008: Cell death upon epigenetic genome methylation: a novel function of methyl-specific deoxyribonucleases[J]. Genome Biol, 9, R163-. doi: 10.1186/gb-2008-9-11-r163
-
Golshahi L, Seed KD, Dennis JJ, Finlay WH, 2008: Toward modern inhalational bacteriophage therapy: nebulization of bacteriophages of Burkholderia cepacia complex[J]. J Aerosol Med Pulm Drug Deliv, 21, 351-360. doi: 10.1089/jamp.2008.0701
-
Hatfull GF, Hendrix RW, 2011: Bacteriophages and their genomes[J]. Curr Opin Virol, 1, 298-303. doi: 10.1016/j.coviro.2011.06.009
-
Hendrix RW. 2008. Phage evolution. In: Bacteriophage Ecology. Abedon ST (ed). Cambridge: Cambridge University Press, pp177-194.
-
Hendrix RW, Smith MCM, Burns RN, Ford ME, Hatfull GF, 1999: Evolutionary relationships among diverse bacteriophages and prophages: All the world's a phage[J]. Proc Natl Acad Sci USA, 96, 2192-2197. doi: 10.1073/pnas.96.5.2192
-
Hudson JA, Billington C, Carey-Smith G, Greening G, 2005: Bacteriophages as biocontrol agents in food[J]. J Food Prot, 68, 426-437. doi: 10.4315/0362-028X-68.2.426
-
Hughes KA, Sutherland IW, Jones MV, 1998: Biofilm susceptibility to bacteriophage attack: the role of phage-borne polysaccharide depolymerase[J]. Microbiology, 144, 3039-3047. doi: 10.1099/00221287-144-11-3039
-
Hyman P, Abedon ST, 2010: Bacteriophage host range and bacterial resistance[J]. Adv Appl Microbiol, 70, 217-248. doi: 10.1016/S0065-2164(10)70007-1
-
Hyman P, Abedon ST, 2012: Smaller fleas: viruses of microorganisms[J]. Scientifica, 2012, 734023-.
-
Iyer VN, James AP, 1978: Single-cell studies on the carrier state of bacteriophage IKe, a virus specific for conjugative plasmids of the N incompatibility and conjugative group[J]. Can J Microbiol, 24, 1595-1601. doi: 10.1139/m78-255
-
Mann NH, 2003: Phages of the marine cyanobacterial picophytoplankton[J]. FEMS Microbiol Rev, 27, 17-34. doi: 10.1016/S0168-6445(03)00016-0
-
May RM, Anderson RM. 1983. Parasite-host coevolution. In: Coevolution. Futuyma DJ, Slatkin M (eds). Sunderland: Sinauer Associates, pp186-206.
-
Moussa SH, Kuznetsov V, Tran TA, Sacchettini JC, Young R, 2012: Protein determinants of phage T4 lysis inhibition[J]. Protein Sci, 21, 571-582. doi: 10.1002/pro.2042
-
Moussa SH, Lawler JL, Young R, 2014: Genetic dissection of T4 lysis[J]. J Bacteriol, 196, 2201-2209. doi: 10.1128/JB.01548-14
-
Payne RJH, Jansen VAA, 2001: Understanding bacteriophage therapy as a density-dependent kinetic process[J]. J Theor Biol, 208, 37-48. doi: 10.1006/jtbi.2000.2198
-
Payne RJH, Jansen VAA, 2003: Pharmacokinetic principles of bacteriophage therapy[J]. Clin Pharmacokinet, 42, 315-325. doi: 10.2165/00003088-200342040-00002
-
Payne RJH, Phil D, Jansen VAA, 2000: Phage therapy: The peculiar kinetics of self-replicating pharmaceuticals[J]. Clin Pharmacol Ther, 68, 225-230. doi: 10.1067/mcp.2000.109520
-
Pratt JH, 1899: Secondary infection of the skin and subcutaneous tissues by the bacillus typhosus[J]. J Boston Soc Med Sci, 3, 170-173.
-
Ryan EM, Gorman SP, Donnelly RF, Gilmore BF, 2011: Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy[J]. J Pharm Pharamcol, 63, 1253-1264. doi: 10.1111/j.2042-7158.2011.01324.x
-
Sanders ME. 1987. Bacteriophages of industrial importance. In: Phage Ecology. Goyal SM, Gerba GP, Bitton G (eds). New York: John Wiley & Sons, pp211-244.
-
Slavcev RA, Hayes S, 2002: Rex-centric mutualism[J]. J Bacteriol, 184, 857-858. doi: 10.1128/JB.184.3.857-858.2002
-
Smith DL, Rooks DJ, Fogg PC, Darby AC, Thomson NR, McCarthy AJ, Allison HE, 2012: Comparative genomics of Shiga toxin encoding bacteriophages[J]. BMC Genomics, 13, 311-. doi: 10.1186/1471-2164-13-311
-
Stent GS. 1963. Molecular biology of bacterial viruses. San Francisco: WH Freeman and Co.
-
Sturino JM, Klaenhammer TR, 2006: Engineered bacteriophage-defence systems in bioprocessing[J]. Nat Rev Microbiol, 4, 395-404. doi: 10.1038/nrmicro1393
-
Tran TA, Struck DK, Young R, 2005: Periplasmic domains define holin-antiholin interactions in T4 lysis inhibition[J]. J Bacteriol, 187, 6631-6640. doi: 10.1128/JB.187.19.6631-6640.2005
-
Tran TA, Struck DK, Young R, 2007: The T4 RI antiholin has an N-terminal signal anchor release domain that targets it for degradation by DegP[J]. J Bacteriol, 189, 7618-7625. doi: 10.1128/JB.00854-07
-
Turner PE, Duffy S. 2008. Evolutionary ecology of multi-phage infections. In: Bacteriophage Ecology. Abedon ST (ed). Cambridge: Cambridge University Press, pp195-216.
-
Wei W, Krone SM, 2005: Spatial invasion by a mutant pathogen[J]. J Theor Biol, 236, 335-348. doi: 10.1016/j.jtbi.2005.03.016
-
Weinfeld H, Paigen K, 1964: Evidence for a new intermediate state of the viral chromosome during cooperative infection by host-modified lambda phage[J]. Virology, 24, 71-83. doi: 10.1016/0042-6822(64)90149-7
-
Werner ER, Christensen JR, 1969: Infection by bacteriophage P1 and development of host-controlled restriction and modification and of lysogenic immunity[J]. J Virol, 3, 363-368.
-
Yamada T, Kawasaki T, Nagata S, Fujiwara A, Usami S, Fujie M, 2007: New bacteriophages that infect the phytopathogen Ralstonia solanacearum[J]. Microbiology, 153, 2630-2639. doi: 10.1099/mic.0.2006/001453-0